Sonidegib (Odomzo) for the Systemic Treatment of Adults With Recurrent, Locally Advanced Basal Cell Skin Cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed.

1. Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome.Leukemia · 2019
   Trial
2. The Epigenetic Landscape and Exposome of Non-Melanoma Skin Cancer: Mechanisms, Biomarkers, and Therapeutic Perspectives.Genes · 2026
   Review
3. Variance in state Medicaid coverage of hedgehog pathway inhibitors in the treatment of basal cell carcinoma.Proceedings (Baylor University. Medical Center) · 2025
   Article
4. Mechanistic insights into medulloblastoma relapse.Pharmacology & therapeutics · 2024
   Review
5. Recommendations for Cost-Conscious Treatment of Basal Cell Carcinoma.Dermatology and therapy · 2023
   Review
6. Supramolecular Synthon Promiscuity in Phosphoric Acid-Dihydrogen Phosphate Ionic Cocrystals.Crystal growth & design · 2022
   Article
7. The Role of Sonic Hedgehog in Human Holoprosencephaly and Short-Rib Polydactyly Syndromes.International journal of molecular sciences · 2021
   Review
8. First reported case of concurrent sonidegib and radiotherapy for recurrent, advanced basal cell carcinoma.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2021
   Article
9. Cancer drug development: The missing links.Experimental biology and medicine (Maywood, N.J.) · 2019
   Review
10. Understanding the Molecular Genetics of Basal Cell Carcinoma.International journal of molecular sciences · 2017
    Review
11. Synthesis and Investigation ofACS medicinal chemistry letters · 2017
    Article
12. Differential pharmacology and clinical utility of sonidegib in advanced basal cell carcinoma.OncoTargets and therapy · 2017
    Review
13. Aging and the treatment of basal cell carcinoma.Clinics in dermatology
    Article
14. A Review of Hedgehog Signaling in Radioresistant Esophageal Cancer: Potential Treatment Target.Technology in cancer research & treatment
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.